Zydus’ Desidustat gets USFDA orphan drug status for sickle cell disease
New Delhi: Zydus Lifesciences on Friday said the US health regulator has granted Orphan Drug Designation to Desidustat, a novel oral product medication for the treatment of Sickle Cell ...
